Caballero-Garcia Melanie, Mendoza-Espinoza Alfredo, Ascanio Silvia, Chero Paula, Rojas Rober, Huberman Yosef Daniel
Research and Development, Quimtia S.A, Centro Ind. Las Praderas de Lurín Mza. B. Lote 1. Lima 16, Lurín CP 15823, Peru.
Bacteriology, INTA EEA Balcarce, RN 226 Km 73, Balcarce CP 07620, Buenos Aires, Argentina.
Vaccines (Basel). 2022 Jun 29;10(7):1043. doi: 10.3390/vaccines10071043.
Worldwide, is the aetiological agent of infectious coryza in poultry. Vaccines are the best means of control, helping reduce clinical signs and colonization of this bacterium. Most vaccines are based on international reference strains, or, lately, regional strains, but, generally, without any information regarding their virulence. The characterization of the pathogenicity of 24 strains of the three Page serogroups, including four variant strains of serogroup B, all isolated from infectious coryza outbreaks in Peru, was performed. After experimental inoculation into the infraorbital sinuses, information regarding their capacity to induce infectious coryza typical clinical signs, spreading, and colonization was recorded. Furthermore, after intraperitoneal inoculation, septicaemia and death were registered. Differences among strains in these parameters were observed, even within strains from the same serogroup. Finally, the four most pathogenic strains, one from each serogroup, were chosen to formulate an experimental vaccine that was tested successfully against homologous challenges in reducing clinical signs and colonization in vaccinated birds compared to unvaccinated ones. This is the first time that strains from Peru were studied thoroughly for their virulence in a search for improving vaccine formulation.
在全球范围内,[病原体名称未给出]是家禽传染性鼻炎的病原体。疫苗是最佳的防控手段,有助于减少该细菌的临床症状和定植。大多数疫苗基于国际参考菌株,或者最近基于区域菌株,但一般而言,没有关于其毒力的任何信息。对从秘鲁传染性鼻炎疫情中分离出的三个佩奇血清群的24株[病原体名称未给出]菌株进行了致病性特征分析,其中包括血清群B的四个变异菌株。在将这些菌株实验性接种到眶下窦后,记录了它们诱导传染性鼻炎典型临床症状、传播和定植的能力。此外,在腹腔接种后,记录了败血症和死亡情况。即使在同一血清群的菌株中,也观察到了这些参数在菌株之间的差异。最后,从每个血清群中挑选出四个致病性最强的菌株,用于制备一种实验性疫苗,与未接种疫苗的禽类相比,该疫苗在针对同源攻击进行测试时,成功地减少了接种疫苗禽类的临床症状和定植。这是首次对来自秘鲁的[病原体名称未给出]菌株进行全面的毒力研究,以寻求改进疫苗配方。